loader
Please Wait
Applying Filters...

AbbVie Header AbbVie Header

X

Annual Sales of benzo[d]isoxazol-3-ylmethanesulfonamide reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Trerief/Excegran (1)

URL Supplier Web Content
Trerief/Excegran
Neurological/Mental Disorders
Yen
14,700
13,300
132
120
13
11
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Trerief/Excegran
Neurological/Mental Disorders
YEN
16,800
15,600
161
150
12
8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Zonegran
Neurological/Mental Disorders
YEN
4,500
5,500
43
53
-10
-18
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Trerief/Excegran
Neurological/Mental Disorders
YEN
16
16
140
145
-5
-3%
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Trerief/Excegran
CNS & Anesthesia
YEN
16
16
157
155
2
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Zonegran
CNS & Anesthesia
YEN
5
5
44
43
1
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Trerief/Excegran
Neurology
YEN
16
16
138
157
-19
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Zonegran
Neurology
YEN
4
5
33
42
-9
-15
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Trerief/Excegran
Neurology
YEN
17
16
128
138
-11
-8
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
Trerief/Excegran
Neurology
YEN
17
17
113
128
-14
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY